thiophenes has been researched along with Hypertriglyceridemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bénardeau, A; Hansen, BC; Meyer, M; Mizrahi, J; Sebokova, E; Tigno, XT | 1 |
| Geeraert, B; Geloen, A; Helin, L; Holvoet, P; Malaud, E; Marguerie, G | 1 |
| Belmadani, S; Boulares, AH; Datta, R; Fallon, K; Hans, CP; Naura, A; Oumouna-Benachour, K; Suzuki, Y; Woods, C | 1 |
| Anderson, PW; Barrett-Connor, E; Cox, DA; Harper, K; Mosca, L; O'Gorman, J; Sarkar, S | 1 |
| Beard, RL; Chandraratna, RA; Escobar, M; Standeven, AM; Thacher, SM; Vuligonda, V; Yuan, YD | 1 |
1 trial(s) available for thiophenes and Hypertriglyceridemia
| Article | Year |
|---|---|
Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia.
Topics: Adult; Aged; Aged, 80 and over; Causality; Female; Humans; Hypertriglyceridemia; Middle Aged; Osteoporosis; Pancreatitis; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiophenes; Triglycerides | 2001 |
4 other study(ies) available for thiophenes and Hypertriglyceridemia
| Article | Year |
|---|---|
Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome.
Topics: Administration, Oral; Animals; Apolipoprotein A-I; Apolipoprotein A-II; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Disease Models, Animal; Eating; Glycated Hemoglobin; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin Resistance; Macaca mulatta; Male; Metabolic Syndrome; Obesity; Oxazoles; PPAR alpha; PPAR gamma; Prediabetic State; Thiophenes; Time Factors; Triglycerides; Weight Loss | 2011 |
CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis.
Topics: Animals; Atherosclerosis; Benzimidazoles; CD36 Antigens; Cell Line; Diabetes Complications; Disease Models, Animal; Dyslipidemias; Humans; Hypertriglyceridemia; Insulin Resistance; Male; Mice; Postprandial Period; Rats; Rats, Wistar; Thiophenes | 2012 |
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Topics: Active Transport, Cell Nucleus; Animals; Aortic Diseases; Apolipoproteins E; Apoptosis; Atherosclerosis; Cells, Cultured; Chemokine CCL2; Cholesterol; Collagen; Crosses, Genetic; Diet, Atherogenic; Drug Evaluation, Preclinical; Foam Cells; Gene Expression Regulation; Genotype; Hydrogen Peroxide; Hypercholesterolemia; Hypertriglyceridemia; Isoquinolines; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Necrosis; NF-kappa B; Oxidative Stress; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Specific Pathogen-Free Organisms; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Triglycerides | 2007 |
Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
Topics: Animals; Benzoates; Carboxylic Acids; Dose-Response Relationship, Drug; Drug Synergism; Fasting; Fatty Acids, Unsaturated; Heparin; Hypertriglyceridemia; Hypoglycemic Agents; Male; Naphthalenes; Rats; Rats, Inbred F344; Receptors, Retinoic Acid; Retinoid X Receptors; Tetrahydronaphthalenes; Thiophenes; Transcription Factors; Triglycerides | 2001 |